matech10qa063008.htm


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549

Form 10-Q/A

(Mark One)

þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2008

o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _______________ to _______________.

Commission file number: 33-23617

Matech Corp
Formerly Material Technologies, Inc.
(Exact name of registrant as specified in its charter)

Delaware
(State or other jurisdiction of
incorporation or organization)

95-4622822
(I.R.S. Employer
Identification No.)

11661 San Vicente Boulevard, Suite 707, Los Angeles, CA 90049
(Address of principal executive offices)

(310) 208-5589
(Issuer’s telephone number)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes R   No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of large accelerated filer,” accelerated filer” and smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer
o
 
Accelerated filer
o
Non-accelerated filer
o
 
Smaller reporting company
R

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes o  No R

As of August 15, 2008, there were 194,459,421 shares of our Class A common stock issued and outstanding.

 
 

 

MATERIAL TECHNOLOGIES, INC.

TABLE OF CONTENTS
 
 
1
   
1
   
1
   
3
   
4
   
7
   
34
  
 
41
  
 
41
  
 
43
  
 
44
  
 
44
  
 
45
  
 
45
  
 
46
  
 
46
  
 
46
  
 
46
   
47
 

 
i


PART I – FINANCIAL INFORMATION

Item 1.       Financial Statements
 
 
MATERIAL TECHNOLOGIES, INC.
     
(A Development Stage Company)
     
       
CONDENSED CONSOLIDATED BALANCE SHEET
 
       
   
June 30,
 
   
2008
 
   
(Unaudited)
 
ASSETS
     
       
Current assets:
     
Cash and cash equivalents
  $ 530,045  
Inventories
    148,964  
Prepaid expenses and other current assets
    62,941  
         
Total current assets
    741,950  
         
Property and equipment, net
    89,632  
Intangible assets, net
    2,302  
Deposit
    2,348  
         
    $ 836,232  
 
 
 
 
 
 
 
 
 
 
 
Continued .. . .

1


MATERIAL TECHNOLOGIES, INC.
     
(A Development Stage Company)
     
       
CONDENSED CONSOLIDATED BALANCE SHEET - Continued
 
       
   
June 30,
 
   
2008
 
   
(Unaudited)
 
   
(Restated)
 
LIABILITIES AND STOCKHOLDERS'  DEFICIT
     
       
Current liabilities:
     
Accounts payable and accrued expenses
  $ 470,017  
Current portion of research and development sponsorship payable
    25,000  
Notes payable
    67,573  
Total current liabilities
    562,590  
         
Accrued legal settlement
    250,000  
Research and development sponsorship payable, net of current portion
    784,100  
Convertible debentures and accrued interest payable, net of discount
    270,973  
Notes payable, long-term
    222,110  
Derivative and warrant liabilities
    75,760,425  
      77,287,608  
         
Total liabilities
    77,850,198  
         
Minority interest in consolidated subsidiary
    825  
         
Commitments and contingencies
       
         
Stockholders' deficit:
       
Class A preferred stock, $0.001 par value, liquidation preference
       
of  $720 per share; 350,000 shares authorized; 337 shares issued
       
and outstanding as of June 30, 2008
    -  
Class B preferred stock, $0.001 par value, liquidation preference of
       
$10,000 per share; 15 shares authorized;  none issued and
       
outstanding as of June 30, 2008
    -  
Class C preferred stock, $0.001 par value, liquidation preference of
       
$0.001 per share; 25,000,000 shares authorized; 1,517 shares issued
       
and outstanding as of June 30,2008
    1  
Class D preferred stock, $0.001 par value, liquidation preference of
       
$0.001 per share; 20,000,000 shares authorized; none shares issued
       
and outstanding as of June 30,2008
    -  
Class E  convertible preferred stock, $0.001 par value, no liquidation
       
preference; 60,000 shares authorized; 53,700 shares issued and
       
outstanding as of June 30,2008
    54  
Class A Common Stock, $0.001 par value, 600,000,000 shares
       
authorized; 168,499 shares issued and 149,330 shares outstanding
       
at June 30,2008
    149  
Class B Common Stock, $0.001 par value, 600,000 shares authorized,
       
issued and outstanding as of June 30,2008
    600  
Warrants subscribed
    10,000  
Additional paid-in-capital
    326,904,859  
Deficit accumulated during the development stage
    (403,834,055 )
Treasury stock ( 293 shares at cost at June 30, 2008)
    (96,399 )
         
Total stockholders' deficit
    (77,014,791 )
         
    $ 836,232  
 
See accompanying notes to the condensed consolidated financial statements.
 
2

 
MATERIAL TECHNOLOGIES, INC.
                             
(A Development Stage Company)
                             
                               
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
 
                               
                           
From October 21, 1983
 
   
For the Three Months Ended
   
For the Six Months Ended
   
(Inception)
 
   
June 30,
   
June 30,
   
through
 
   
2007
   
2008
   
2007
   
2008
   
June 30, 2008
 
   
(Unaudited)
   
(Unaudited)
   
(Unaudited)
   
(Unaudited)
   
(Unaudited)
 
         
(Restated)
         
(Restated)
   
(Restated)
 
Revenues:
                             
Research and development
  $ -     $ -     $ -     $ -     $ 5,392,085  
Revenue from bridge testing
    22,778               66,745       1,090       319,714  
Other
    -       -       -       -       274,125  
                                         
Total revenues
    22,778       -       66,745       1,090       5,985,924  
                                         
Costs and expenses:
                                       
Research and development
    3,294,575       150,847       3,512,076       309,840       20,872,829  
General and administrative
    41,016,474       5,517,443       62,475,638       25,845,768       329,341,009  
Modification of research and development sponsorship agreement
    -       -       -       -       5,963,120  
Loss on settlement of lawsuits
    -       -       -       -       1,267,244  
                                         
Total costs and expenses
    44,311,049       5,668,290       65,987,714       26,155,608       357,444,202  
                                         
Loss from operations
    (44,288,271 )     (5,668,290 )     (65,920,969 )     (26,154,518 )     (351,458,278 )
                                         
Other income (expense):
                                       
Loss on modification of convertible debt
    -       (964,730 )     -       (964,730 )     (378,485 )
Loss on subcription receivables
                                    (1,368,555 )
Interest expense
    (612,416 )     (606,028 )     (1,590,651 )     (977,019 )     (12,717,212 )
Other-than-temporary impairment of marketable securities available for sale
            -                       (9,785,947 )
Net unrealized and realized loss of marketable securities
    (8,556,211 )             (8,556,219 )     (8 )     (9,398,226 )
Change in fair value of investments derivative liability
    -       -       -       -       (210,953 )
Change in fair value of derivative and warrant liabilities
    6,942,597       (71,103,676 )     22,920,017       (62,544,101 )     (18,957,012 )
Interest income
    12,594       3,080       15,966       15,523       482,405  
Other
    -       -       -       -       (25,992 )
                                         
Other income (expense), net
    (2,213,436 )     (72,671,354 )     12,789,113       (64,470,335 )     (52,359,977 )
                                         
Loss before provision for income taxes
    (46,501,707 )     (78,339,644 )     (53,131,856 )     (90,624,853 )     (403,818,255 )
                                         
Provision for income taxes
    -       -       (800 )     (800 )     (15,800 )
                                         
Net loss
  $ (46,501,707 )   $ (78,339,644 )   $ (53,132,656 )   $ (90,625,653 )   $ (403,834,055 )
                                         
Per share data:
                                       
Basic and diluted net loss per share
  $ (448.38 )   $ (500.20 )   $ (580.45 )   $ (614.04 )        
Weighted average Class A common shares outstanding - basic and diluted
    103,710       156,617       91,538       147,589          
 
 
 
 
See accompanying notes to the condensed consolidated financial statements.
 
3

 
MATERIAL TECHNOLOGIES, INC.
                 
(A Development Stage Company)
                 
                   
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
 
                   
               
From October 21, 1983
 
   
For the Six Months Ended
   
(Inception)
 
   
June 30,
   
through
 
   
2007
   
2008
   
June 30, 2008
 
   
(Unaudited)
   
(Unaudited)
   
(Unaudited)
 
         
(Restated)
   
(Restated)
 
                   
Cash flows from operating activities:
                 
Net loss
  $ (53,132,656 )   $ (90,625,653 )   $ (403,834,055 )
Adjustments to reconcile net loss to net cash used in operating activities:
                       
Loss on modification of convertible debt
    -       964,730       378,485  
Impairment loss
    19,255,875       -       21,391,528  
Loss on charge off of subscription receivables
    -               1,368,555  
Issuance of common stock for services
    15,558,944       3,625,200       210,110,040  
Increase in debt for services and fees
    -       1,100,000       5,556,625  
Officer's stock based compensation
    30,000,000       19,885,333       86,460,675  
Issuance of common stock for modification of research and development sponsorship agreement
    -               7,738,400  
Change in fair value of derivative and warrant liabilities
                    (41,351,889 )
Net realized and unrealized loss on marketable securities
    8,556,200               7,895,705  
Other-than-temporary impairment of marketable securities available for sale
    -               9,785,946  
Legal fees incurred for note payable
                    1,456,142  
Accrued interest expense added to principal
    156,901       135,816       1,630,821  
Amortization of discount on convertible debentures
    1,431,081       824,072       10,930,350  
Change in fair value of investments derivative liability
    (22,920,017 )     62,544,101       65,767,423  
Accrued interest income added to principal
    (5,428 )     25,433       (279,565 )
Depreciation and amortization
    1,951       10,621       238,405  
Other non-cash adjustments
    -               (114,730 )
(Increase) decrease in trade receivables
    91,787       108,661       (50,328 )
(Increase) decrease in inventories
    -       (86,748 )     (148,964 )
(Increase) decrease in prepaid expenses and other current assets
    (22,500 )     (17,257 )     225,316  
Increase in deposits
    -               (2,348 )
(Decrease) increase in accounts payable and accrued expenses
    (141,766 )     (130,968 )     2,377,927  
                         
Net cash used in operating activities
    (1,169,628 )     (1,636,659 )     (12,469,536 )
                         
                         
Cash flows from investing activities:
                       
Proceeds from the sale of marketable securities
    95,006       300,000       3,758,476  
Purchase of marketable securities
    (302,038 )     -       (2,206,379 )
Investment in certificate of deposits and commerical paper
    (700,177 )     (565,000 )     (1,965,000 )
Maturities of certificate of deposits and commercial paper
    -       1,565,000       1,965,000  
Payment received on officer loans
    -       3,803       880,058  
Funds advanced to officers
    -       -       (549,379 )
Proceeds received in acquisition of consolidated subsidiaries
                    600,000  
Purchase of property and equipment
    -       (17,167 )     (373,419 )
Investment in joint ventures
    -       -       (102,069 )
Proceeds from foreclosure
    -       -       44,450  
Proceeds from the sale of property and equipment
    -       -       19,250  
Payment for license agreement
    -       -       (6,250 )
                         
Net cash provided by (used in) investing activities
    (907,209 )     1,286,636       2,064,738  
 
Continued .. . .
 
4

 
 
MATERIAL TECHNOLOGIES, INC.
                 
(A Development Stage Company)
                 
                   
CONSOLIDATED STATEMENTS OF CASH FLOWS - Continued
 
                   
               
From October 21, 1983
 
   
For the Six Months Ended
   
(Inception)
 
   
June 30,
   
through
 
   
2007
   
2008
   
June 30, 2008
 
   
(Unaudited)
   
(Unaudited)
   
(Unaudited)
 
         
(Restated)
   
(Restated)
 
                   
Cash flow from financing activities:
                 
Proceeds from the sale of  common stock and warrants
  $ 2,850,000     $ 18,624     $ 9,464,577  
Proceeds from convertible debentures and other notes payable
    200,000       55,000       2,102,766  
Proceeds from the sale of preferred stock
    100,000       -       473,005  
Costs incurred in offerings
    (773,779 )     -       (1,130,932 )
Capital contributions
    -       -       301,068  
Purchase of treasury stock
    (17,381 )     (3,266 )     (170,641 )
Principal reduction on notes payable
    (26,671 )             (100,000 )
Payment on proposed reorganization
    -       -       (5,000 )
                         
Net cash provided by (used in) financing activities
    2,332,169       70,358       10,934,843  
                         
Net change in cash and cash equivalents
    255,332       (279,665 )     530,045  
                         
Cash and cash equivalents, beginning of period
    129,296       809,710       -  
                         
Cash and cash equivalents, end of period
  $ 384,628     $ 530,045     $ 530,045  
                         
Supplemental disclosure of cash flow information:
                       
Interest paid during the period
  $ 2,669     $ 281          
Income taxes paid during the period
  $ 800     $ 800          
 
Supplemental disclosures of non-cash investing and financing activities:
                 
2008
               
                 
During the six months ended June 30, 2008, the Company issued 4,230 shares of its Class A common shares in
the conversion of $491,132 of convertible debt.
 
                 
During the six months ended June 30, 2008, the Company issued 13,207 shares of its Class A common stock
for consulting  services valued at $3,668,400.
 
                 
During the six months ended June 30, 2008, the Company issued 378 shares of its Class A common stock
pursuant to the anti-dilution provisions of a settlement agreement.
                 
During the six months ended June 30, 2008. a former employee returned 450 shares of the Company's Class A
common stock to treasury which were subsequently cancelled.
                 
During the six months ended June 30, 2008. the Company's president returned 30,000 shares of the Company's
Class A common stock to treasury which were subsequently cancelled.
                 
During the six months ended June 30, 2008, the Company issued 34,500 shares of its Class A common stock
in consideration of the exercise of cashless warrants. The Company accrued derivative liability in connection with the
granting of the warrants, which had a balance of $1,151,900 on the date of exercise. The liability balance was credited to equity.
                 
During the six months ended June 30, 2008, the Company issued 78 shares of its Class A common stock for $18,624.
                 
During the six months ended June 30, 2008, the Company issued 1,040 shares of the Company's common stock
was issued through the conversion of 1,300 shares of the Company's Class E preferred shares.
                 
During the six months ended June 30, 2008, the Company contingent obligation to Mr. Beck under a settlement agreement
was reduced to $0, therefore the Company reduced its legal settlement liability by the remaining accrued provision of $230,000,
which was credited to equity.
           
                 
During the six months ended June 30, 2008, the Company obtained $55,000 through the issuance of convertible debt. In connection
with this debt, the Company recognized a beneficial conversion feature of $28,140 that was credited to equity.
 
 
Continued .. . .
 
 
 
During the six months ended June 30, 2008, the Company recognized compensation expense of $8,800 on the grant of
options to its employees and officers for the purchase of 800.000 shares of Class A common stock. In addition, during the six months
the Company granted options to its President for the purchase of 400,000,000 shares of its Class A common stock and  granted options
to a consultant to purchase 15,390,546 shares of its Class A common stock. The Company recognized a derivative liability of $6,400,000
on the granting of these options.
           
                 
2007
               
                 
During the six months ended June 30, 2007, the Company issued 2,839 shares of its Class A common stock
for consulting  services valued at $13,158,944.
 
                 
During the six months ended June 30, 2007, the Company received $1,000,000 in consideration of issuing 2,500 units.
Each unit consists of one share of the Company's Class A common stock and a warrant to purchase
one share of the Company's common stock at a price of $.60 per share. In connection with the private offering
the Company paid $239,065 in fees and issued warrants to purchase 2,118 shares of the Company's
common stock at a price of $1.20 per share.
 
                 
During the six months ended June 30, 2007, the Company issued 50,000 shares its Class E Series convertible
preferred stock in exchange for receiving all of the outstanding shares of Stress Analysis Technologies, Inc.  ("SATI").
The Company valued the acquisition at $19,355,875 of which $19,255,875 was allocated to the acquired license.
Durng the six months ended June 30, 2007, the Company deemed the license to be impaired and charged of the
$19,255,875 to operation. In connection with this transaction, the Company issued an additional 5,000 preferred
shares valued at $2,400,000 for fees in connection with the purchase. The $2,400,000 was charged to operations.
                 
During the  six months ended June 30, 2007, the Company issued 10,800 shares in escrow pursuant to an agreement it has with
with its convertible debenture holders. During 2007, 5,800 shares of Class A common stock was issued  to certain
debenture holders in the conversion of  $580,000 of indebtedness. In addition, for the redemption of 1,000 shares by certain debenture
holders, the balance due on the debentures  was increased by $600,000.
                 
During the six months ended June 30, 2007, the Company received 50 shares of prior issued common stock
which was subsequently cancelled.
           
 
 
 
 
 
 
 
 
 
 
 
 
 
See accompanying notes to the condensed consolidated financial statements.
6

MATERIAL TECHNOLOGIES, INC.
(A DEVELOPMENT STAGE COMPANY)

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the three months and six months ended June 30, 2008 and 2007

 
NOTE 1 - BASIS OF PRESENTATION
 
1.  BASIS OF PRESENTATION
 
The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and pursuant to the rules and regulations of the Securities and Exchange Commission.  Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been omitted pursuant to such rules and regulations.

In the opinion of management, all adjustments, consisting of normal and recurring adjustments, necessary for a fair presentation of the financial position and the results of operations for the periods presented have been included.  The operating results of the Company on a quarterly basis may not be indicative of operating results for the full year.  For further information, refer to the financial statements and notes included in Material Technologies, Inc.’s (the Company’s) Form 10-KSB for the year ended December 31, 2007.
 
Reverse Stock Split
 
Effective on October 3, 2008, the Company declared a 1-for-1,000 reverse split of the Company’s Class A common stock. All share amounts and per share amounts have been adjusted throughout these financial statements for the reverse stock split.
 
Restatement of Financial Statements

The Company entered into an agreement with the Palisades convertible note holders to modify the terms of the convertible notes with an effective date of June 16, 2008 (See Note 9). In addition, effective on October 3, 2008, the Company declared a 1-for-1,000 reverse split of the Company’s Class A common stock. All share amounts and per share amounts have been adjusted throughout the financial statements for the reverse stock split.  Based upon these two reansactions. the Company has restated its financial statements for the three and six months ended June 30, 2008 as follows:

Statements of operations:
 
   
For the Three Months Ended
 
   
June 30, 2008
 
   
As Originally Stated
   
Adjustments
   
As Corrected
 
Revenues:
                 
Research and development
  $ -     $ -     $ -  
Revenue from bridge testing
    -               -  
Other
    -               -  
 
7

MATERIAL TECHNOLOGIES, INC.
(A DEVELOPMENT STAGE COMPANY)

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the three months and six months ended June 30, 2008 and 2007

 
Total revenues
    -             -       -  
                               
Costs and expenses:
                             
Research and development
    150,847                     150,847  
General and administrative
    5,517,443                     5,517,443  
                               
Total costs and expenses
    5,668,290             -       5,668,290  
                               
Loss from operations
    (5,668,290 )           -       (5,668,290 )
                               
Other income (expense):
                             
Interest expense
    (397,973 )     1 )     (208,055 )     (606,028 )
Loss on modification of convertible debt
    -       2 )     (964,730 )     (964,730 )
Change in fair value of derivative liabilities
    (6,036,711 )     3 )     (65,066,965 )     (71,103,676 )
Interest income
    3,080                       3,080  
Other expense, net
    (6,431,604 )             (66,239,750 )     (72,671,354 )
                                 
Loss before provision for income taxes
    (12,099,894 )             (66,239,750 )     (78,339,644 )
                                 
Provision for income taxes
    -               -       -  
                                 
Net loss
  $ (12,099,894 )           $ (66,239,750 )   $ (78,339,644 )
                                 
Per share data:
                               
Basic and diluted net loss per share
  $ (77.26 )           $ (422.94 )   $ (500.20 )
  
                               
Weighted average Class A common shares outstanding - basic and diluted
    156,617               156,617       156,617  
 
1)  To record additional interest of $16,597 on the increased balance of debt and amortization of increased discount totalling $191,458.
2)  To record loss on modification of convertible debt.
3)  To expense increase in derivative liability due to the reduction in conversion price of convertible debt and granting of warrants to purchase 35M shares of common stock.
 
8

MATERIAL TECHNOLOGIES, INC.
(A DEVELOPMENT STAGE COMPANY)

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the three months and six months ended June 30, 2008 and 2007


   
For the Six Months Ended
 
   
June 30, 2008
 
   
As Originally Stated
         
Adjustments
   
As Corrected
 
Revenues:
                       
Research and development
  $ -             -     $ -  
Revenue from bridge testing
    1,090             -       1,090  
Other
    -             -       -  
                               
Total revenues
    1,090             -       1,090  
                               
Costs and expenses:
                             
Research and development
    309,840                     309,840  
General and administrative
    25,845,768                     25,845,768  
                               
Total costs and expenses
    26,155,608             -       26,155,608  
                               
Loss from operations
    (26,154,518 )           -       (26,154,518 )
                               
Other income (expense):
                             
Interest expense
    (768,964 )     1 )     (208,055 )     (977,019 )
Loss on modification of convertible debt
    -       2 )     (964,730 )     (964,730 )
Change in fair value of derivative liabilities
                               
Interest income
                            -  
Other expense, net
    -                       -  
Net unrealized and realized loss of marketable securities
    (8 )                     (8 )
Change in fair value of derivative liabilities
    2,522,864       3 )     (65,066,965 )     (62,544,101 )
Interest income
    15,523                       15,523  
      1,769,415               (66,239,750 )     (64,470,335 )
                                 
Loss before provision for income taxes
    (24,385,103 )             (66,239,750 )     (90,624,853 )
                                 
Provision for income taxes
    (800 )             -       (800 )
                                 
Net loss
  $ (28,200,501 )           $ (66,239,750 )   $ (90,625,653 )
                                 
Per share data:
                               
Basic and diluted net loss per share
  $ (0.31 )           $ (723.63 )   $ (990.04 )
  
                               
Weighted average Class A common shares outstanding - basic and diluted
    91,538               91,538       91,538  
 
1)  To record additional interest of $16,597 on the increased balance of debt and amortization of increased discount totaling $191,458.
2)  To record loss on modification of convertible debt.
3)  To expense increase in derivative liability due to the reduction in conversion price of convertible debt and granting of warrants to purchase 35M shares of common stock.
 
 
9

MATERIAL TECHNOLOGIES, INC.
(A DEVELOPMENT STAGE COMPANY)

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the three months and six months ended June 30, 2008 and 2007

 
Balance sheet:
 
   
June 30, 2008
 
   
As Originally Stated
         
Adjustments
   
As Corrected
 
                         
Current liabilities:
                       
Accounts payable and accrued expenses
  $ 470,017           $ -     $ 470,017  
Current portion of research and development sponsorship     payable
    25,000             -       25,000  
Notes payable
    67,573             -       67,573  
Convertible debentures and accrued interest payable, net of discount
    3,323,466       1 )     (3,289,571 )     -  
              2 )     (33,895 )        
                                 
Total current liabilities
    3,886,056               (3,323,466 )     562,590  
                      -          
Accrued legal settlement
    250,000               -       250,000  
Research and development sponsorship payable, net of current portion
    784,100               -       784,100  
Convertible debentures and accrued interest payable, net of discount
    29,024       3 )     4,254,301       270,973  
              3 )     (4,254,301 )        
              4 )     241,949          
Notes payable, long-term
    222,110               -       222,110  
Derivative and warrant liabilities
    6,439,158       1 )     4,254,301       75,760,425  
              5 )     65,066,966          
      7,724,392               69,563,216       77,287,608  
 
 
10

MATERIAL TECHNOLOGIES, INC.
(A DEVELOPMENT STAGE COMPANY)

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the three months and six months ended June 30, 2008 and 2007

 
Total liabilities
    11,610,448               66,239,750       77,850,198  
                                 
Minority interest in consolidated subsidiary
    825                       825  
                                 
Commitments and contingencies
                               
                                 
Stockholders' deficit:
                               
Preferred Stock
    55                       55  
Class A Common Stock,
    149,330       6 )     (149,181 )     149  
Class B Common Stock,
    600               -       600  
Warrants subscribed
    10,000               -       10,000  
Additional paid-in-capital
    326,755,678       6 )     149,181       326,904,859  
Deficit accumulated during the development stage
    (337,594,305 )     1       (964,730 )     (403,834,055 )
              2 )     33,895          
              4 )     (241,949 )        
              5 )     (65,066,966 )        
                                 
Treasury stock
    (96,399 )             -       (96,399 )
                      -          
Total stockholders' deficit
    (10,775,041 )             (66,239,750 )     (77,014,791 )
                      -          
    $ 836,232             $ -     $ 836,232  
 
1) To record gain on extinquishmment of balance of convertible debt prior to the modification of the debt and to record derivative warrant liability on the issuance of  35M warrants.
2) To adjust accrued interest on note balance at June 16, 2008.
3) To record balance of new convertible debt and related discount based upon the terms of the June 16, 2008 agreement.
4) To record accrued interest on the modified balance of convertible debt and amortization modified discount.
5) To adjust derivative warrant liability at June 30, 2008 to fair value.
6) To adjust common stock for October 2008 1000:1 reverse stock split.
 
 
11

MATERIAL TECHNOLOGIES, INC.
(A DEVELOPMENT STAGE COMPANY)

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the three months and six months ended June 30, 2008 and 2007

 
Going Concern
 
The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. As shown in the accompanying restated financial statements, the Company is in the development stage and, at June 30, 2008, has an accumulated deficit of $403,834,055, continues to sustain operating losses on a monthly basis, and expects to incur operating losses for the foreseeable future.  Management of the Company will need to raise additional debt and/or equity capital to finance future activities.  However, no assurances can be made that current or anticipated future sources of funds will enable the Company to finance future periods’ operations.  In light of these circumstances, substantial doubt exists about the Company’s ability to continue as a going concern. These condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded assets or liabilities that might be necessary should the Company be unable to continue as a going concern.

NOTE 2 – RECENT ACCOUNTING PRONOUNCEMENTS

In March 2008, the FASB issued Statement of Financial Accounting Standards No. 161, “Disclosures about Derivative Instruments and Hedging Activities” (“SFAS 161”). SFAS 161 amends and expands the disclosure requirements of SFAS 133, “Accounting for Derivative Instruments and Hedging.” SFAS 161 is effective for fiscal years beginning after November 15, 2008. The Company will adopt SFAS 161 in the first quarter of 2009 and currently expect such adoption to have no impact on its results of operations, financial position, or cash flows.

In April 2008, the FASB issued Staff Position No. 142-3, “Determination of the Useful Life of Intangible Assets” (“FSP 142-3”). FSP 142-3 amends the factors that should be considered in developing renewal or extension assumptions used to determine the useful life of a recognized intangible asset under FASB Statement of Financial Accounting Standards No. 142, “Goodwill and Other Intangible Assets”. FSP 142-3 is effective for Format, Inc. in the first quarter of 2009. The Company presently has no such intangible assets. If and at such time as such assets are acquired, the Company will apply SFAS 160.

In May 2008, the FASB issued Statement of Financial Accounting Standards No. 162, “The Hierarchy of Generally Accepted Accounting Principles” (“SFAS 162”). SFAS 162 identifies the sources of accounting principles and the framework for selecting the principles to be used in the preparation of financial statements of nongovernmental entities that are presented in conformity with generally accepted accounting principles in the United States. SFAS 162

12

MATERIAL TECHNOLOGIES, INC.
(A DEVELOPMENT STAGE COMPANY)

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the three months and six months ended June 30, 2008 and 2007


will become effective 60 days following Securities and Exchange Commission (“SEC”) approval of the Public Company Accounting Oversight Board (PCAOB) amendments to AU Section 411, “The Meaning of Present Fairly in Conformity With Generally Accepted Accounting Principles.” The Company does not anticipate the adoption of SFAS 162 to have a material impact on our results of operations, financial position, or cash flows.

In June 2008, the FASB issued Staff Position No. EITF 03-6-1, “Determining Whether Instruments Granted in Share-Based Payment Transactions Are Participating Securities” (“EITF 03-6-1”). EITF 03-6-1 addresses whether instruments granted in share-based payment transactions are participating securities prior to vesting, and therefore, need to be included in the earnings allocation in calculating earnings per share under the two-class method described in FASB Statement of Financial Accounting Standards No. 128, “Earnings per Share.” EITF 03-6-1 requires companies to treat unvested share-based payment awards that have non-forfeitable rights to dividend or dividend equivalents as a separate class of securities in calculating earnings per share. EITF 03-6-1 is effective for fiscal years beginning after December 15, 2008. EITF 03-6-1 is effective for Format, Inc. in the first quarter of 2009. We are currently assessing the impact of EITF 03-6-1, but do not expect that such adoption will have a material effect on our results of operations, financial position, or cash flows.

NOTE 3  INVESTMENTS
 
Commercial Paper
 
During the six months ended June 30, 2008, the Company received $2,992,952 including accrued interest of $13,521, on maturities of various investments in a bank’s commercial paper. Also during the six months, the Company reinvested $1,580,000. The balance of the Company’s investment in commercial paper at June 30, 2008 was $0.

NOTE 4 - INVENTORIES

Inventories at June 30, 2008 consist of the following:

Finished goods
  $ 142,964  
 
Inventories consist of sensors and other parts used in the Company’s bridge testing operations.

NOTE 5 – PROPERTY AND EQUIPMENT

Property and equipment at June 30, 2008 consisted of the following:

13

MATERIAL TECHNOLOGIES, INC.
(A DEVELOPMENT STAGE COMPANY)

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the three months and six months ended June 30, 2008 and 2007

 
Office and computer equipment
  $ 27,645  
Manufacturing equipment
    230,522  
      258,167  
Less accumulated depreciation
    (168,535 )
    $ 89,632  

Depreciation charged to operations for the three months ended June 30, 2008 and 2007 amount to $5,041 and $707, respectively.  Depreciation charged to operations for the six months ended June 30, 2008 and 2007 amount to $10,083 and $1,413, respectively.

NOTE 6 – INTANGIBLE ASSETS

Intangible assets consist of the following at June 30, 2008:
 
   
Period of
Amortization
     
Patent costs
17 years
  $ 28,494  
License agreement (see Note 7)
17 years
    6,250  
Website
5 years
    5,200  
        39,944  
Less accumulated amortization
      (37,642 )
      $ 2,302  
 
Amortization charged to operations for the three months ended June 30, 2008 and 2007 was $269, and $267, respectively. Amortization charged to operations for the six months ended June 30, 2008 and 2007 was $538, and $538, respectively.
 
Estimated amortization expense for remaining life of the intangibles is as follows:
 
2008
  $ 538  
2009
  $ 1,076  
2010
  $ 688  


14

MATERIAL TECHNOLOGIES, INC.
(A DEVELOPMENT STAGE COMPANY)

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the three months and six months ended June 30, 2008 and 2007

 
NOTE 7 – LICENSE AGREEMENTS

University of Pennsylvania

In 1993, the Company has entered into a license agreement with the University of Pennsylvania (the “University”) for the development and marketing of EFS. 

Under the terms of the agreement, the Company issued to the University 1 share of its common stock, and a 5% royalty on sales of the product.  The Company valued the license agreement at $6,250.  The license terminates upon the expiration of the underlying patents, unless sooner terminated as provided in the agreement.  The Company is amortizing the license over 17 years.

In addition to the license agreement, the Company also agreed under a modified workout agreement relating to a prior sponsorship agreement to pay the University, retroactive to January 1, 2005, the balance of $760,831, which accrues interest at a monthly rate of 0.5% simple interest.  The Company is obligated to pay $25,000 annually due on the anniversary date of the Workout Agreement.  Further, the Company is also obligated to pay within ten days following the filing of the Company’s Forms 10-QSB or 10-KSB an amount equal to 10% of the Company’s operating income (as defined) as reflected in the quarterly and annual filings.  Under the revised terms of the Workout Agreement, the Company’s CEO’s annual cash salary is capped at $250,000.  The Company agreed to pay the University an amount equal to any cash salary paid to Mr. Bernstein in excess of the $250,000, which will be credited against the balance of the amounts due under the agreement.

Interest expense charged to operations during the three months ended June 30, 2008 and 2007 amounted $9,885 and $10,662, respectively.  Interest expense charged to operations during the six months ended June 30, 2008 and 2007 amounted $19,770 and $15,984, respectively.  The balance of the obligation (including accrued interest) at June 30, 2008 was $809,100 and is reflected in research and development sponsorship payable in the accompanying condensed consolidated balance sheet.  The current portion represents the minimum annual payment under the Workout Agreement, while the remaining balance is reflected as non-current as the Company does not expect to be required to make additional payments during the next twelve months.

 North Carolina Agricultural and Technical State University (“NCAT”)

The Company acquired this sublicense in its purchase of Monitoring.  The license allows the Company to utilize technology covered through two patents licensed to NCAT.  Under the license, the Company is required to support collaborative research under the direction of the actual inventor of the patented processes and to deliver to NCAT within three months of the effective date of the license a report indicating the Company’s plans for commercializing the subject technology.

15

MATERIAL TECHNOLOGIES, INC.
(A DEVELOPMENT STAGE COMPANY)

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the three months and six months ended June 30, 2008 and 2007

 
In partial consideration for the license, the Company must pay to NCAT a royalty equal to 3.5% of net sales of licensed products sold by the Company, its affiliates and from sublicensees.  In the case of sub-licensees, the Company must pay NCAT 25% of any income, revenue, or other financial consideration received on any sublicense including but not limited to, advance payments, license issue fees, license maintenance fees, and option fees.  Minimum royalties are due as follows:
 
Year beginning

August 2, 2009
  $ 30,000  
August 2, 2010
  $ 30,000  
August 2, 2011 and each year thereafter
  $ 50,000  

The license remains in full force for the life of the last-to-expire patent.  The license can be terminated by the Company by giving 90-day written notice and thereupon stop the manufacturing, use, or sale of any product developed under the license.  In addition, the license terminates if the Company defaults under the royalty provisions of the license or files for bankruptcy protection.

ISIS Innovation Limited (“ISIS”)

In the 2007 acquisition of SATI, the Company acquired a license to develop and market the patented process known as “X-Ray diffraction method”. Under the terms of the exclusive license with ISIS Innovation Limited, the licensor was granted back the right to utilize the process on a perpetual, royalty-free basis. The licensee is responsible for all costs associated with maintaining and protecting the patent. In the case of sub-licensees, the Company must pay ISIS 25% of any income, revenue, or other financial consideration received on any sublicense including but not limited to, advance payments, license issue fees, license maintenance fees, and option fees, In addition, a 2.5% royalty on net sales is due with minimum royalties as follows:
 
Year beginning
January 29, 2010
  $ 21,000  
January 29, 2011
  $ 32,000  
January 29, 2012
  $ 42,000  
 

16

MATERIAL TECHNOLOGIES, INC.
(A DEVELOPMENT STAGE COMPANY)
 
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
 
For the three months and six months ended June 30, 2008 and 2007

 
Iowa State University Research Foundation (“ISURF”)
 
In the 2007 acquisition of NATI, the Company acquired a license to develop and market the patented process known as “Nondestructive evaluation and stimulate industrial innovation”. Under the terms of the non-exclusive license with ISURF, the Company is required to develop products for sale in the commercial market and to provide ISURF with a development plan and bi-annual development report until the first commercial product sale. The Company has the right to sublicense the patented process to third companies, but is required to pay a royalty fee of 25% of amounts earned by the Company under the sublicenses. For each product sold under the license, the Company is required to pay ISURF a royalty equal to 3% of the selling price with the following minimum royalty payments:

Year beginning

January 1, 2009
  $ 10,000  
January 1, 2010
  $ 20,000  
January 1, 2011 and each year thereafter
  $ 30,000  

NOTE 8 – NOTES PAYABLE

On May 27, 1994, the Company borrowed $25,000 from a shareholder.  The loan is evidenced by a promissory note bearing interest at 6.5 percent.  The note is secured by the Company’s patents and matured on May 31, 2002.  The loan has not been paid and is now in default.  As additional consideration for the loan, the Company granted to the shareholder a 1% royalty interest in the Fatigue Fuse and a 0.5% royalty interest in EFS (see Note 10).  The balance due on this loan as of June 30, 2008 was $57,573.  Interest charged to operations during the three months ended June 30, 2008 and 2007 was $406 and $406, respectively.  Interest charged to operations during the six months ended June 30, 2008 and 2007 was $811 and $811, respectively. 

On April 28, 2003, the Company borrowed $10,000 from an unrelated third party.  The loan is unsecured, non-interest bearing and due on demand.

On March 5, 2007, the Company borrowed $200,000 from a shareholder. The loan is evidenced by an unsecured promissory note which is assessed interest at an annual rate of 8%. The note matures on March 5, 2009 when the principal and accrued interest becomes fully due and payable. The balance of the loan including accrued interest at June 30, 2008 is $222,110.  Interest charged to operations during the three months ended June 30, 2008 and 2007 was $4,343 and $4,012, respectively.  Interest charged to operations during the six months ended June 30, 2008 and 2007 was $8,602 and $5,152, respectively. 


17

MATERIAL TECHNOLOGIES, INC.
(A DEVELOPMENT STAGE COMPANY)

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the three months and six months ended June 30, 2008 and 2007

 
NOTE 9 – CONVERTIBLE DEBENTURES

Palisades

On September 23, 2003, the Company entered into a Class A Secured Convertible Debenture (the “Debentures”) with Palisades, pursuant to which Palisades agreed to loan the Company up to $1,500,000.  On December 1, 2003, after Palisades had funded $240,000 of the original Debentures, the Company entered into additional Class A Secured Convertible Debentures with two additional investors, pursuant to which such investors would loan the Company up to $650,000 each, and the Company agreed that Palisades would not make additional advances under the Debentures.  The Company received a total of $1,125,000 under the Debentures.

Effective June 16, 2008, the Company and Investor Group (“Palisades’) entered into Settlement Agreement and General Release whereby Palisades agreed to extend the maturity date of the convertible debentures to December 31, 2009. Under the modified terms of the underlying Notes,  the Company is required to make minimum monthly interest payments totaling $10,000, the first payment being made in August 2008.  Under the settlement and related escrow agreement, the Company is required to deposit a number of shares equal to 9.99% of its issued and outstanding Class A Common Stock into a brokerage account in the name of Agent at a firm to be determined from time to time by Agent.  The Company also agreed to modify the terms of the notes to include the following restrictions:

 
·
If an Event of Default occurs under the Notes, and, if such Event of Default is curable, such Event of Default continues for a period of 30 days without being cured, then the 10% interest rate set forth in the Notes will be increased to a Default Interest Rate of 18% per annum, and the total balance of principal and accrued interest of the debentures shall bear interest at the Default Interest Rate from the date of the occurrence of such Event of Default

 
·
In addition, the entry of any judgment against the Company in excess of $150,000, regardless of where, how, to whom or under what agreement such liability arises, shall be an Event of Default under the Debentures, unless (i) the Company pays such judgment within 60 days, or (ii) the Company duly files an appeal of such judgment and execution of such judgment is stayed.  Finally, the entry of any order or judgment in favor of any judgment creditor or other creditor attaching the assets of the Company shall be an Event of Default under these debentures.  The conversion price of the debentures shall not be at any time more than $0.10 per share, regardless of any combination of shares of the Common Stock of the Company by reverse split or otherwise.

18

MATERIAL TECHNOLOGIES, INC.
(A DEVELOPMENT STAGE COMPANY)

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the three months and six months ended June 30, 2008 and 2007

 
 
·
If an Event of Default occurs which is not cured within its applicable cure period, if it is curable, the conversion price of these debentures after such cure period has expired shall be reduced to half of the pre-Event of Default conversion price.  For clarification, if the conversion price before an Event of Default were the lesser of 50% of market price or $0.10, then the new conversion price would be the lesser of 25% of market price or $0.05.

 
·
The Company shall not issue any shares of its Class A Common Stock without a legend stating that such shares may not be sold, transferred, pledged, assigned or alienated for a period of at least one year following the date of the issuance of such certificate, other than shares issued to or with the written consent of the Holder.  Notwithstanding the foregoing, this provision shall not apply to (i) any shares issued to purchasers in a financing where the Company receives net proceeds of at least Five Hundred Thousand Dollars ($500,000) and the shares are sold for not less than fifty percent (50%) of the closing price of the Company’s common stock reported as of the closing date of such financing, and (ii) any shares issued in connection with an acquisition of assets by the Company where (a) the Company provides to the Holder a fairness opinion as to the value of the acquired assets, and (b) the Company receives assets that are worth at least fifty percent (50%) of the closing price per share of the Company’s common stock as of the closing date of the acquisition.

 
·
The Company shall not enter into any agreement pursuant to which any party other than the Holder has pre-emptive rights, the right to receive shares of any class of securities of the Company for no additional consideration, the right to receive a set, pre-determined percentage of the outstanding shares of the Company for any period of time, or any other similar right that has the effect of maintaining a set percentage of the issued and/or outstanding shares of any class or classes of the capital stock of the Company.

 
·
The Company shall not enter into any agreement giving another party anti-dilution protection unless (1) all shares received pursuant to such provision are subject to a two-year lock-up from the date of issuance, and (2) all such shares received are subject to a “dribble-out,” following the two-year lock-up, restricting their sale to not more than 1/20th of 5% of the previous month’s total trading volume in any single trading day.

 
·
The Company will not file any Registration Statement on Form S-8 nor issue any shares registered on Form S-8, exclusive of shares currently registered on Form S-8.  However, when the total capital in the Company’s cash account drops below $500,000, the Company may issue up to $30,000 worth of securities registered on Form S-8, valued at the market price of the common stock on the date of issuance, per month, non-cumulative.  Any issuance of S-8 shares will be supported by an opinion of the Company’s counsel that such issuance complies in all respects with federal securities

19

MATERIAL TECHNOLOGIES, INC.
(A DEVELOPMENT STAGE COMPANY)

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the three months and six months ended June 30, 2008 and 2007


 
laws.  This opinion will be provided to the legal representative of the Holder upon request.  Further, the Company will ensure that every entity or individual that receives S-8 shares will be subject to a “dribble-out” restricting their sale to not more than 1/20th of 2% of the previous month’s total trading volume in any single trading day, non-cumulative.  The above described dribble-out is not an aggregate sale restriction for all entities and individuals receiving S-8 shares;

 
·
The Company has informed the Holder that it is considering completing a one-for-one-thousand reverse split of its common stock, as described in an Information Statement filed by the Company on or about April 25, 2008.  The Company acknowledges that the conversion price of the Debenture shall not be effected by any such reverse split, and that after giving effect to such reverse split, the conversion price shall remain the lesser of (i) 50% of the averaged ten closing prices for the Company’s Common Stock for the ten trading days immediately preceding the Conversion Date or (ii) $0.10.  The Holder consents to this action.  The parties acknowledge that the Company is not obligated to complete this reverse-split, or any reverse split.

 
·
The shareholder lockup provisions will not apply to up to any shares held by Mr. Robert Bernstein, and sold by him personally in a bona-fide sale to an unrelated, unaffiliated third party; provided, that (i) the number of shares sold shall not exceed Two Million Five Hundred Thousand Dollars ($2,500,000) worth of stock, calculated based on the number of shares sold multiplied by the closing price of the stock on the date such shares are sold (if a market trade) or transferred on the books of the transfer agent (if a private transfer).  Once Two Million Five Hundred Thousand Dollars ($2,500,000) worth of stock has been sold as calculated above, the lockup on whatever remains of the shares owned by Mr. Bernstein (if any) goes back into effect.  In this regard, if Mr. Bernstein sells any of his shares without legend, then he may only sell up to 1/20th of 5% of the previous month’s total trading volume in any single trading day, and he may not sell more than 1% of the issued and outstanding shares of Matech during any 90 day period.  Further, if Mr. Bernstein sells any of his shares, he must have such shares transferred on the books of the transfer agent within five business days of the sale.  Mr. Bernstein shall comply with all reporting requirements under Section 16 of the Securities Exchange Act of 1934, as amended.

As further consideration for the Note Holders to extend the maturity date of the debentures and to enter into the Settlement Agreement, the Company agreed to pay an extension fee and a settlement fee totaling $554,910, which was added to the outstanding balance of the debentures as of June 16, 2008 and grant the holders warrants to purchase 35,000,000 shares of the Company’s Class A common stock at an exercise price of the lesser of (i) $0.001 per share, or (ii) 50% of market price   The warrants expire on October 16, 2016. Payment of the warrant price may be in cash or cashless, at the option of the warrant holder.

20

MATERIAL TECHNOLOGIES, INC.
(A DEVELOPMENT STAGE COMPANY)

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the three months and six months ended June 30, 2008 and 2007

 
The Company accounted for the modification of the convertible debt pursuant to EITF 96-19 “Debtor's Accounting for a Modification or Exchange of Debt Instruments” and recognized a loss on the modification of $964,730 that was charged to operations.

Further, Per EITF 00-19, paragraph 4, these convertible debentures do not meet the definition of a “conventional convertible debt instrument” since the debt is not convertible into a fixed number of shares.  The debt can be converted into common stock at a conversions price that is a percentage of the market price; therefore, the number of shares that could be required to be delivered upon “net-share settlement” is essentially indeterminate.  Therefore, the convertible debenture is considered “non-conventional,” which means that the conversion feature must be bifurcated from the debt and shown as a separate derivative liability. The Company recognized a derivative liability of $4,254,301 on June 16, 2008, with an offset to debt discount in the same amount.

In addition, since the convertible debenture is convertible into an indeterminate number of shares of common stock, it is assumed that the Company could never have enough authorized and unissued shares to settle the conversion of the warrants into common stock.  Therefore, the warrants issued in connection with this transaction are also shown as a derivative liability.

In connection with the settlement agreement, the Company entered into a consulting agreement with an affiliate of the debenture holders for a term commencing on May 1, 2008 and terminating no earlier than May 1, 2010. For the duration of the agreement, the Consultant agrees to assist the Company with implementing the Company’s business plan, assist it in identifying, analyzing, structuring and negotiating acquisitions and related activities. Under the terms of the consulting agreement, the Company agreed to pay a fee of $20,000 per month and reimburse the Consultant for reasonable expenses it incurred relating to the Company’s business. As further consideration, the Company granted warrants to the consultant to purchase 5,000,000 shares of the Company’s Class A common stock at an exercise price of the lesser of (i) $0.10 per share, or (ii) 50% of market price   The warrants expire on October 16, 2013. Payment of the warrant price may be in cash or cashless, at the option of the warrant holder. the Warrant Shares are stated after giving effect to a one for one-thousand reverse stock split completed in October 2008.

The balance of the Debenture, including accrued interest, at June 30, 2008 was $241,950 (net of unamortized discount of $4,028,669).  Interest charged to operation in on the face amount of the debentures for the three months ended June 30, 2008 and 2007 was $106,578 and $64,614, respectively.  Interest charged to operation on the face amount of the debentures for the six  months ended June 30, 2008 and 2007 was $226,909 and $101,302,

21

MATERIAL TECHNOLOGIES, INC.
(A DEVELOPMENT STAGE COMPANY)

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the three months and six months ended June 30, 2008 and 2007

 
respectively.  Amortization expense of the discount also charged to operations as interest expense for the three months ended June 30, 2008 and 2007 amounted to $482,651 and $528,617, respectively. Amortization expense of the discount charged to operations as interest expense for the six months ended June 30, 2008 and 2007 amounted to $809,044 and $1,424,414, respectively.

At June 30, 2008, the fair value of the derivative liabilities relating to the above-indicated convertible debt and warrants amounted to $68,753,699 and $567,567, respectively.

GGI

During the six months ended June 30, 2008, the Company issued 122,512 shares of its Class A common stock through the conversion of the total balance due on the convertible debt amounting to $91,384.  Interest charged to operations relating to this debt during the three months ended June 30, 2008 and 2007 amounted to $0 and $1,185, respectively. Interest charged to operations relating to this debt during the six months ended June 30, 2008 and 2007 amounted to $281 and $2,356, respectively.

In addition, since the Debentures allow the holders to convert the outstanding principal amount into shares of the Company’s common stock at a discount to fair value, the Company recorded the fair value of the conversion feature of $40,000 in 2005. Amortization expense of the discount also charged to operations as interest expense for the three months ended June 30, 2008 and 2007 amounted to $0 and $3,333, respectively.  Amortization expense of the discount also charged to operations as interest expense for the six months ended June 30, 2008 and 2007 amounted to $13,333 and $6,666, respectively.

Mitchell

On April 25, 2008, the Company borrowed $55,000 from an individual in exchange for issuing a convertible promissory note. The note is assessed interest at an annual rate of 4.71%. Principal and accrued interest is fully due and payable on April 25, 2011. Until the note and accrued interest are fully paid, the lender has the right to convert the amount due him into shares of the Company’s Class A common stock equaling 3,5% of the shares outstanding on date of conversion.

As the number of shares that could be required to be delivered upon “net-share settlement” is essentially indeterminate, the convertible debenture must be bifurcated from the debt and shown as a separate derivative liability. The Company recognized a beneficial conversion feature of $28,140 and a derivative liability of $31,658 at June 30, 2008.

Interest charged to operations for the three and six months ended June 30, 2008 amounted to $468. The beneficial conversion feature is treated as a discount against the face amount of the debt and is amortized into interest expense over the term of note. Amortization expense on the discount charged to operations for the three and six months ended June 30, 2008 totaled $1,696.

22

MATERIAL TECHNOLOGIES, INC.
(A DEVELOPMENT STAGE COMPANY)

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the three months and six months ended June 30, 2008 and 2007

 
NOTE 10 – COMMITMENTS AND CONTINGENCIES

Royalties

A summary of royalty interests that the Company has granted and are outstanding as of June 30, 2008 follows:

  
 
Fatigue Fuse
   
EFS
   
Server
Array
System
   
 
 
 
X-Ray Diffraction Method
   
Nondestructive evaluation and stimulate industrial innovation
 
                               
Variety Investments, Ltd.
    5.00 %     -       -       -       -  
University of Pennsylvania (see Note 7)
                                       
Net sales of licensed products
    -       7.00 %     -       -       -  
Net sales of services
    -       2.50 %     -       -       -  
NCAT (see Note 7)
                                       
Net sales of licensed products
    -       -       3.50 %     -       -  
Sublicensing income
    -       -       25.00 %     -       -  
ISIS  (see Note 7)
                                       
Net sales of licensed products
    -       -       -       2.5 %     -  
Sublicensing income
    -       -       -       25.00 %     -  
ISURF (see Note 7)
                                       
Net sales of licensed products
    -       -       -       -       3.0 %
Sublicensing income
    -       -       -       -       25.00 %
Shareholder
    1.00 %     0.50 %     -       -       -  

Litigation

In December 2006, the Company entered into a settlement agreement and release agreement, as well as irrevocable escrow instructions, to settle the lawsuit filed on March 8, 2006.  As consideration under the settlement, the Company issued 5,000,000 shares of its common stock to Mr. Beck, with the shares to be held by an escrow agent and distributed to Mr. Beck monthly with a trading limit equal to 8% of the previous month’s trading volume of the

23

MATERIAL TECHNOLOGIES, INC.
(A DEVELOPMENT STAGE COMPANY)

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the three months and six months ended June 30, 2008 and 2007


Company’s common stock, until Mr. Beck has received a total of $800,000.  As the Company has guaranteed this debt to Mr. Beck in the amount of $800,000, the Company originally recorded a liability for this amount at the time of the settlement.  As Mr. Beck receives proceeds from the sale of his shares in to the market, the Company is reducing its guarantee by that amount.  As of June  30, 2008, the Company’s guarantee to Mr. Beck was $0.

The Company has also been named as a defendant in a lawsuit alleging breach of contract due to the Company’s failure to pay certain amounts due to a consultant for services.  The Company asserts that the contract was unenforceable due to a number of factors.  Legal counsel has advised the Company that it is premature to estimate the outcome or the range of damages that may occur if the case is not settled in the Company’s favor.

In the ordinary course of business, the Company may be from time to time involved in other various pending or threatened legal actions.  The litigation process is inherently uncertain and it is possible that the resolution of such matters might have a material adverse effect upon our financial condition and/or results of operations.  However, in the opinion of our management, matters currently pending or threatened against us are not expected to have a material adverse effect on the Company’s financial position or results of operations.

Indemnities and Guarantees

During the normal course of business, the Company has made certain indemnities and guarantees under which it may be required to make payments in relation to certain transactions.  These indemnities include certain agreements with the Company’s officers under which the Company may be required to indemnify such person for liabilities arising out of their employment relationship.  They also include indemnities made to the holders of the convertible debentures, Mr. Beck, with regards to his settlement with the Company, and the sellers of investments in securities.  The duration of these indemnities and guarantees varies, and in certain cases, is indefinite.  The majority of these indemnities and guarantees do not provide for any limitation of the maximum potential future payments the Company would be obligated to make.  Historically, the Company has not been obligated to make significant payments for these obligations and no liability has been recorded for these indemnities and guarantees in the accompanying consolidated balance sheet.

NOTE 11 – EMPLOYEE BENEFIT PLAN

On December 14, 2007, the Company adopted a 401k retirement plan for its employees. To be eligible to participate in the plan, an employee must be at least 21 years for age and work for the Company for six consecutive months. Company contributions and employee match are discretionary. During the six months ended June  30, 2008, the Company did not contribution to the plan.


24

MATERIAL TECHNOLOGIES, INC.
(A DEVELOPMENT STAGE COMPANY)

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the three months and six months ended June 30, 2008 and 2007


NOTE 12  STOCKHOLDERS' EQUITY

 Class A Preferred Stock

The holders of the Class A convertible preferred stock have a liquidation preference of $720 per share.  Such amounts shall be paid on all outstanding Class A preferred shares before any payment shall be made or any assets distributed to the holders of the common stock or any other stock of any other series or class ranking junior to the shares as to dividends or assets.

These shares are convertible to shares of the Company's common stock at a conversion price of $0.72 (“initial conversion price”) per share of Class A preferred stock that will be adjusted depending upon the occurrence of certain events.  The holders of these preferred shares shall have the right to vote and cast that number of votes which the holder would have been entitled to cast had such holder converted the shares immediately prior to the record date for such vote.  The holders of these shares shall participate in all dividends declared and paid with respect to the common stock to the same extent had such holder converted the shares immediately prior to the record date for such dividend.

Class B Preferred Stock

The Company has designated 15 shares of Class B preferred stock, of which no shares have been issued.  The holders of Class B preferred shares are entitled to a liquidation preference of $10,000 per share.  Such amounts shall be paid on all outstanding Class B preferred shares before any payment shall be made or any assets distributed to the holders of common stock or of any other stock of any series or class junior to the shares as to dividends or assets, but junior to Class A preferred shareholders.  Holders of Class B preferred shares are not entitled to any liquidation distributions in excess of $10,000 per share.

The shares are redeemable by the holder or the Company at $10,000 per share.  The holders of these shares shall have the right to vote at one vote per Class B preferred share and shall participate in all common stock dividends declared and paid according to a formula as defined in the series designation.

Class C Preferred Stock

Each shareholder of Class C preferred stock is entitled to receive a cumulative dividend of 8% per annum for a period of two years.  Dividends do not accrue or are payable except out of earnings before interest, taxes, depreciation and amortization.  At June 30, 2007, no dividends are payable to Class C preferred shareholders.  Holders of the Class C preferred stock are junior to holders of the Company’s Class A and B preferred stock, but hold a higher

25

MATERIAL TECHNOLOGIES, INC.
(A DEVELOPMENT STAGE COMPANY)

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the three months and six months ended June 30, 2008 and 2007


position than common shareholders in terms of liquidation rights.  Holders of Class C preferred stock have no voting rights.  Holders of Class C preferred stock have the right to convert their shares to common stock on a 300-to-1 basis.

The Company requires an approval of at least two-thirds of the holders of Class C preferred shareholders to alter or change their rights or privileges by way of a reverse stock split, reclassification, merger, consolidation or otherwise, so as to adversely affect the manner by which the shares of Class C preferred stock are converted into common shares.

Class D Preferred Stock

Holders of Class D preferred stock have a $0.001 liquidation preference, no voting rights and are junior to holders of all classes of preferred stock but senior to common shareholders in terms of liquidation rights.  Class D preferred stockholders are entitled to dividends as declared by the Company’s Board of Directors, which have not been declared as of June 30, 2008.  Holders of Class D preferred stock have the right to convert their shares to common stock on a 300-to-1 basis. As of June  30, 2008, there were no Class D Preferred shares outstanding.

Class E Convertible Preferred Stock

On January 26, 2007, the Company amended its certificate of incorporation by filing a certificate of designation of rights, preferences, privilege and restrictions of the Company’s new created Class E convertible preferred stock.  The Company has authorized 60,000 shares, each with an original issue price of $19.50 per share.  In each calendar quarter, the holders of the then outstanding Class E Convertible Preferred Stock shall be entitled to receive non-cumulative dividends in an amount equal to 5% of the original purchase price per annum. All dividends may be accrued by the Corporation until converted into common shares. After one year from the issuance date, the holders of Class E convertible preferred stock have the right to convert the preferred shares held into shares of the Company’s common stock at the average closing bid price of the ten days prior to the date of conversion. Class E Preferred Shares have no liquidation preference, and has ten votes per share.

In connection with the acquisition of SATI, the Company issued 50,000 shares of Class E convertible preferred which were valued at the shares original purchase price of $19.50 per share. The Company also issued an additional 5,000 shares to a consultant in connection with the SATI acquisition, which were valued at $97,500 and charged to equity as costs of the offering.

During the six month period ended June 30, 2008, 1,300 shares of Class E convertible preferred stock were converted into 1,039,746 shares of the Company’s Class A common stock.


26

MATERIAL TECHNOLOGIES, INC.
(A DEVELOPMENT STAGE COMPANY)

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the three months and six months ended June 30, 2008 and 2007


Class A Common Stock

The holders of the Company's Class A common stock are entitled to one vote per share of common stock held.

During the six months ended June 30, 2008, the Company issued 53,433 and cancelled 30,450 shares of its common stock.

From time to time, the Company issues its common shares and holds the shares in escrow on behalf of another party until consummation of certain transactions.  The following is a reconciliation of shares issued and outstanding as of June 30, 2008:
 
Issued shares
    168,499  
Less shares held in escrow:
       
Shares issued to the Company and held in escrow
    (3,357 )
Shares held in escrow pursuant to agreement debenture holders
    (8,000 )
Contingent shares held related to the Beck settlement for antidilution purposes (see Note 10)
    (7,806 )
Other
    (6 )
      (19,169 )
         
Outstanding shares (including shares committed)
    149,330  
 
Class B Common Stock

The holders of the Company's Class B common stock are not entitled to dividends, nor are they entitled to participate in any proceeds in the event of a liquidation of the Company.  However, the holders are entitled to 600,000 votes for each share of Class B common stock held.

Common Shares Issued for Non Cash Consideration

The value assigned to shares issued for services were charged to operations in the period issued.


27

MATERIAL TECHNOLOGIES, INC.
(A DEVELOPMENT STAGE COMPANY)

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the three months and six months ended June 30, 2008 and 2007


2008
 
During the six months ended June 30, 2008, the Company issued 53,434 shares of its Class A common stock, of which 4,230 shares were issued in the conversion of $491,131 of convertible debt, 13,207 shares for consulting and other services valued at $3,668,400, 378 shares issued pursuant to an anti-dilutive provision of a settlement agreement, valued at par, and 34,500 shares issued on the exercise of 34,500,000 warrants. Upon the issuing of the 34.500 shares, the Company credited its related derivative warrant liability of $1,151,900 to equity. In addition, during the six-month period, the Company issued 1,040 shares of common stock on the conversion of 1,300 shares of Class E preferred shares.

During the six-months ended June 30, 2008, the Company’s President returned 30,000 shares of common stock for cancellation. Also during the same six-month period, another 450 common shares were returned for cancellation.

Stock Options

The Company has the following stock option plans:  The 1998 Stock Plan (“the 1998 Plan”), the 2002 Stock Issuance/Stock Plan (“the 2002 Plan”), the 2003 Stock Option, SAR and Stock Bonus Consultant Plan (“the 2003 Plan”), the 2006 Non-Qualified Stock Grant and Option Plan (the “2006 Plan”), and the 2006/2007 Non-Qualified Stock Grant and Option Plan (the “2006/2007 Plan”), and the 2008 Incentive and Nonstatutory Stock Option Plan..

In September 1998, the Company adopted the 1998 Plan and reserved 2,667 shares of its common stock for grant under the plan.  Eligible participants include employees, advisors, consultants and officers who provide services to the Company.  The option price is 100% of the fair market value of a share of common stock at either the date of grant or such other day as the as the Board may determine.  The plan expires upon the earlier of all reserved shares being granted or September 10, 2008.

In February 2002, the Company adopted the 2002 Plan and reserved 66,667 shares of its common stock for grant under the plan.  Eligible plan participants include employees, advisors, consultants and officers who provide services to the Company.  The option price is 100% of the fair market value of a share of common stock at either the date of grant or such other day as the Board may determine.  The plan expires upon the earlier of all reserved shares being awarded or December 31, 2007.

In April 2006, the Company adopted the 2006 Plan and reserved 100,000 shares of its common stock for grant.  Eligible plan participants include independent consultants, and the Company may issue shares of stock or options may be granted at any price. The plan expires upon the  earlier of all reserved shares being granted or April 18, 2016.


28

MATERIAL TECHNOLOGIES, INC.
(A DEVELOPMENT STAGE COMPANY)

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the three months and six months ended June 30, 2008 and 2007

 
In December 2006, the Company adopted the 2006/2007 Plan and reserved 3,000,000 shares of its common stock for grant.  Eligible plan participants include independent consultants, and the Company may issue the shares of the stock or option may be granted at any price.  The plan expires upon the earlier of all reserved shares being granted or December 1, 2016.
 
On April 22, 2008, the Board of Directors adopted the 2008 Incentive and Nonstatutory Stock Option Plan for its employees, directors, and consultants. The Company initially reserved 100,000,000 shares of its Class A common shares to be issued under the plan. The plan was later amended to increase the number of shares reserved to 400,000,000. On April 22, 2008, the Company granted Mr. Bernstein options under the plan to purchase 30,000,000 shares of the Company’s Class A common stock at a price of $.04 per share. The options expire ten years after grant. On April 23, 2008, the Company granted Mr. Bernstein options under the plan to purchase 300,000,000 shares of the Company’s Class A common stock at a price of $.00462 per share. The options expire ten years after grant. On May 4, 2008, the Company granted Mr. Bernstein options under the plan to purchase 70,000,000 shares of the Company’s Class A common stock at a price of $.0077 per share. The options expire ten years after grant.

These option agreements allow for cashless exercises when the fair market value of the Company’s common stock exceeds the respective exercise price. The Company deemed these options to be derivatives based upon their terms and as of June 30, 2008, the Company recognized a derivative liability of $6,400,000 that was charged to operations.

On April 30, 2008, the Company granted options under its 2006/2007 Non-Qualified Stock Grant and Option Plan to purchase a total of 800,000 shares of its common stock to three officers and its Corporate Secretary. The exercise price of the options is $.011 per share and they expire on April 30, 2016. The options were valued using the Black-Scholes option-pricing model using the following assumptions: term of 8 years, a risk-free interest rate of 3.29%, a dividend yield of 0% and volatility of 659%.  Compensation recognized on the above option grants was $8,800 and was charged to operations.

On April 9, 2008, pursuant to a consulting agreement, the Company granted options to a consultant to purchase 15.390.546 shares of Class A common stock at a price of $.025 per share. The options expire on April 9, 2018. The terms of the grant allow for cashless exercises when the fair market value of the Company’s common stock exceeds the respective exercise price. The Company deemed these options to be derivatives based upon their terms and as of June 30, 2008, the Company recognized a derivative liability of $400,154 that was charged to operations.

Stock Warrants

During the year ended December 31, 2006 the Company issued 35,000,000 warrants to Palisades as part of the Company’s modification of Palisades’ convertible debentures (see Note 9).  The Company has valued these warrants using a market capitalization method in accordance with its established accounting policy.  The value of these warrants on the date of grant was $1,668,000 and was included as a component of the Company’s derivative liability

29

MATERIAL TECHNOLOGIES, INC.
(A DEVELOPMENT STAGE COMPANY)

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the three months and six months ended June 30, 2008 and 2007


balance (see Note 9).   The warrants are exercisable at a price of the lesser of: (a) $0.001 per share; (b) 50% of the market price on the date of exercise. During the six months ended June  30, 2008, 34,500,000 warrants were exercised.

In addition to the 500,000 warrants as indicated above, the Company has granted as part of a private offering, warrants to purchase 4,618,334 shares of its Class A Common Stock.

Under the terms of its June 16, 2008 settlement agreement with Palisades, the Company granted warrants to the debenture holders to purchase a total of 35,000,000 shares of the Company’s common stock at a price per share of the lesser of (i) $0.001 per share, or (ii) 50% of market price. The Warrants expire on October 16, 2016. The Company also granted warrants to purchase 5,000,000 shares if its common stock to an affiliate of the debenture holders as part consideration for consultant services. The 5,000,000 warrants are exercisable at a price per share of the lesser of (i) $0.10 per share, or (ii) 50% of market price   The Warrants expire on October 16, 2013. The terms of the respective warrant agreements allow the warrant holder certain piggyback registration rights.

The following table summarizes the warrants and options outstanding at June 30, 2008:

         
Weighed
 
   
Options/
   
Average
 
   
Warrants
   
Exercise
 
   
Outstanding
   
Price
 
Balance – December 31, 2007
    35,131,667     $ 0.003  
Granted
    456,190,546     $ 0.007  
Exercised
    (34,500,000 )     $ (0.001 )
Forfeited
    (13,333 )     $ (0.001 )  
                 
Balance – June 30, 2008
    456,808,880     $ 0.007  


30

MATERIAL TECHNOLOGIES, INC.
(A DEVELOPMENT STAGE COMPANY)

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the three months and six months ended June 30, 2008 and 2007

 
NOTE 13 – RELATED PARTY TRANSACTIONS
 
For additional related party transactions, see Note 8. 
 
As of June 30, 2008, the Company was owed $5,151 from its President.  The loan is assessed interest at an annual rate of 10%.  Interest credited to operations relating to this loan during the three months ended June 30, 2008 and 2007 amounted to $218 and $197, respectively  Interest credited to operations relating to this loan during the six months ended June 30, 2008 and 2007 amounted to $430 and $887, respectively

On November 21, 2006, the Company entered into a stock grant and general release agreement with the Company’s CEO, for the purpose of showing the Company’s appreciation for the CEO’s work over the past several years.  Under the agreement, the CEO was issued 30,000,000 shares of the Company’s Class A common stock, restricted in accordance with Rule 144, and subject to forfeiture back to the Company in accordance with the terms of the agreement, if he is not employed by the Company for 3 years from the date of the agreement.  Additionally under the terms of the agreement, the CEO has released the Company from any and all claims he may have against the Company for any monies owed to him as of the date of the agreement.  The value assigned to the shares issued to the CEO has been determined to be $180,000,000 based on the Company’s trading price of the shares on date of issuance.  The value will be recorded as additional compensation expense over the 36 month term of the agreement.  On April 29, 2008, the President returned the 30,000,000 shares to the Company for cancellation. The Company ceased recognizing compensation when these shares were returned. During the three months ended June 30, 2008 and 2007, the Company charged to operations $4,833,333 and $15,000,000, respectively. During the six months ended June 30, 2008 and 2007, the Company charged to operations $19,833,333 and $30,000,000, respectively.

NOTE 14 – FAIR VALUE
 
The Company adopted Statement of Financial Accounting Standard No. 157, Fair Value Measurements (“SFAS 157”), to measure the fair value of certain of its financial assets required to be measured on a recurring basis. The adoption of SFAS 157 did not impact the Company’s consolidated financial position or results of operations.  SFAS 157 establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).  SFAS 157 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants on the measurement date. A fair value measurement assumes that the transaction to sell the asset or transfer the liability occurs in the principal market for the asset or liability. The three levels of the fair value hierarchy under SFAS 157 are described below:
 
Level 1. Valuations based on quoted prices in active markets for identical assets or liabilities that an entity has the ability to access.
 

31

MATERIAL TECHNOLOGIES, INC.
(A DEVELOPMENT STAGE COMPANY)

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the three months and six months ended June 30, 2008 and 2007

 
The Company’s Level 1 assets include cash accounts payable and accrued expenses. Due to the short term maturity of these liabilities, the Company valued them at net book value.
 
Level 2. Valuations based on quoted prices for similar assets or liabilities, quoted prices for identical assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities.
 
The Company’s Level 2 assets consist of a derivative and warrant liability. The Company determines the fair value of its Level 2 assets based upon the trading prices of its common stock on the date of issuance and when applicable, on the last day of the quarter. The Company uses the Black-Sholes Option Model in valuing the fair value of level 2 assets.
 
Level 3. Valuations based on inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.
 
The Company had no level 3 assets as of June 30, 2008.
 
The table below presents a reconciliation for all assets and liabilities measured at fair value on a recurring basis.
 
          June 30, 2008  
          Fair Value Measurements*  
   
Level 1
   
Level 2
   
Level 3
   
Fair Value
 
                         
Assets                        
Cash   $ 530,045     $ -     $ -     $ 530,045  
Liabilities                                
Accounts payable and accrued expenses   $ 470,017     $ -     $ -     $ 470,017  
Derivative and warrant liability     $ -     $ 75,760,425     $ -     $ 75,760,425  
 
 
 
 
Derivative and
 
 
 
  Warrant Liability  
         
Balance – January 1, 2008
  $ 10,113,923  
 
Total realized and unrealized losses
       
 
Included in operations
    62,544,101  
  Liability accrued on issuance of        
 
convertible long-term debt
    4,254,301  
  Liability credited to equity on        
 
exercise of 34,500 warrants
    (1,151,900 )
Balance – June 30, 2008
  $ 75,760,425  
 

32

MATERIAL TECHNOLOGIES, INC.
(A DEVELOPMENT STAGE COMPANY)

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the three months and six months ended June 30, 2008 and 2007


NOTE 15 – SUBSEQUENT EVENTS

In July 2008, the Company issued 7,538 shares of its common stock through a conversion of 4,450 shares of its Class E preferred stock.

In July 2008, a consultant returned to the Company 208 shares of its common stock for cancellation.

In July 2008, the Company issued 10,000 shares of its common stock in cancellation of $20,000 of convertible debt.

In July 2008, the Company entered into a financing agreement to borrow a total of $1,000,000 through the issuance of a convertible note. Interest accrue on the outstanding loan balance at an annual rate of 10% per annum. Prinicipal is due on the maturity date with accrued interest due quarter; however,  the Company has the right to defer interest payments until the maturity date so long as it does not have positive earnings  before interest, taxes, depreciation and amortization (“EBITDA”).  The maturity date of the note is December 31, 2011.  The balance owed on the note, including accrued interest, is convertible at the election of the holder into do many free trading shares of the Company’s common stock based upon a conversion price of the lesser of (i) 50% of the averaged ten closing prices for the Company’s common stock for the ten (10) trading days immediately preceding the conversion date or (ii) $0.10.  The Company is required to reserve the number of  free trading shares of Common Stock required pursuant to and upon the terms set forth in the Subscription Agreement (approximately 100,000,000 shares), to permit the conversion of this Debenture. The Company has pledged significantly all of its assets as collateral on this loan.

In August 2008, the Company issued 20,000 shares of its common stock in cancellation of $40,000 of convertible debt.
 
October 3, 2008, the Company declared a 1-for-1,000 reverse split of the Company’s Class A common stock.

 
 
 
 
 
 
 
 
 
33

 
Item 2.       Management’s Discussion and Analysis of Financial Condition and Results of Operations

Disclaimer Regarding Forward Looking Statements

Our Management’s Discussion and Analysis contains not only statements that are historical facts, but also statements that are forward-looking (within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934).  Forward-looking statements are, by their very nature, uncertain and risky.  These risks and uncertainties include international, national and local general economic and market conditions; demographic changes; our ability to sustain, manage, or forecast growth; our ability to successfully make and integrate acquisitions; raw material costs and availability; new product development and introduction; existing government regulations and changes in, or the failure to comply with, government regulations; adverse publicity; competition; the loss of significant customers or suppliers; fluctuations and difficulty in forecasting operating results; changes in business strategy or development plans; business disruptions; the ability to attract and retain qualified personnel; the ability to protect technology; and other risks that might be detailed from time to time in our filings with the Securities and Exchange Commission.

Although the forward-looking statements in this report reflect the good faith judgment of our management, such statements can only be based on facts and factors currently known by them.  Consequently, and because forward-looking statements are inherently subject to risks and uncertainties, the actual results and outcomes may differ materially from the results and outcomes discussed in the forward-looking statements.  You are urged to carefully review and consider the various disclosures made by us in this report and in our other reports as we attempt to advise interested parties of the risks and factors that may affect our business, financial condition, and results of operations and prospects.

Overview

We research and develop technologies that detect and measure metal fatigue.  We have developed two products: (1) the Fatigue Fuse; and (2) the Electrochemical Fatigue Sensor.  We generate very little revenue from the sale and licensing of our products, and thus we are a development stage company. 

Our biggest challenge is funding the commercialization of our products until we can generate sufficient revenue to support our operations.  We try to keep our overhead low and utilize outside consultants as much as possible in order to reduce expenses, and thus far we have been successful in raising enough capital through loans and financing to fund operations.  For the foreseeable future, we plan to continue to raise capital in this manner.

Our consolidated financial statements are prepared using the accrual method of accounting in accordance with accounting principles generally accepted in the United States of America and have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities in the normal course of business.  We have sustained operating losses since our inception (October 21, 1983).  In addition, we have used substantial amounts of

34


working capital in our operations.  Further, at June 30, 2008, the deficit accumulated during the development stage amounted to approximately $403,834,055. 

In view of these matters, realization of a major portion of the assets in the accompanying consolidated balance sheet is dependent upon our ability to meet our financing requirements and the success of our future operations.  During 2007, we received approximately $4,000,000 in private financing, primarily from the sale of equity and debt securities.  Thus far in 2008, we have received approximately $1,073,600 in private financing, also primarily from the sale of equity and debt securities.  We plan to continue to raise funds through the sale of our securities for the foreseeable future. In addition in 2007, we received contracts to inspect certain bridges with nine states which generated gross revenue of approximately $201,917.  Thus far in 2008, we have received contracts to inspect certain bridges with nine states which will generated gross revenue of approximately $55,000.  We have begun marketing our current technologies while continuing to develop new methods and applications.  We will need to raise additional capital to finance future activities and no assurances can be made that current or anticipated future sources of funds will enable us to finance future operations.  In light of these circumstances, substantial doubt exists about our ability to continue as a going concern.  The consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded assets or liabilities that might be necessary should we be unable to continue as a going concern.

Results of Operations for the Six Months Ended June 30, 2008 as Compared to the Six Months Ended June 30, 2007

As discussed further in Notes 1 and 9 to the accompanying financial statements, effective June 18, 2008, the Company entered into an agreement with the Palisades convertible  note holders to modify the terms of the convertible debt. The Company has restated its 2008 financial statements to include the effect of this modification agreement. Further in October 2008, the Company authorized a 1000:1 reverse stock split. Reference to all stock issuances in 2008 has been restated to consider this reverse stock split.

Revenues and Loss from Operations

Our revenue, research and development costs, general and administrative expenses, and loss from operations for the six months ended June 30, 2008 as compared to the six months ended June 30, 2007 are as follows:

   
Six months
Ended
June 30, 2008
   
Six months
Ended
June 30, 2007
   
Percentage
Change
 
                   
Revenue   $ 1,090     $ 66,745       (98.36 )%
Research and development costs    $ 309,840     $ 3,512,076       (91.17 )%
General and administrative expenses     $ 25,845,768     $ 62,475,638       (58.63 )%
Loss from operations    $ (26,154,518 )   $ (65,920,969 )     (60.32 )%
 

 
Our revenues were derived exclusively from bridge testing.

Of the $309,840 in research and development costs for the six months ended June 30, 2008, $159,355 was incurred in salaries to our in-house engineering staff which included an officer and director, $115,985 was paid to outside consultants and for related expense reimbursements, and we valued the issuance of 150 shares of our common stock that were issued to one consultant at $34,500. Of the $159,355 is R&D salaries, $4,400 was compensation expense recognized on the granting of options to our staff to purchase a total of 400 shares of our common stock.

Of the $3,512,076 in research and development costs for the six months ended June 30, 2007, $66,625 was incurred in salaries to our in-house engineering staff which included an officer and director, $300,351 was paid to outside consultants and for related expense reimbursements, and we valued the issuance of 2,116 shares of our common stock that were issued to various consultants at $3,145,100. 

General and administrative expenses were $25,845,768 and $62,475,638, respectively, for the six months ended June 30, 2008 and 2007.  The major expenses incurred during each of the quarters were:

   
Six months
Ended
June 30, 2008
   
Six months
Ended
June 30, 2007
 
             
Consulting services    $ 4,790,293     $ 12,177,839  
Officer’s salary      251,000       125,000  
Officer’s stock based compensation     19,887,533       30,000,000  
Secretarial salaries     65,497       44,576  
Office expense     36,865       36,453  
Professional fees      444,936       535,782  
Rent       16,197       15,258  
Marketing & Promo      111,214       138,786  
Impairment loss        --       19,255,875  
Payroll taxes     35,008       17,461  
Travel      67,830       69,614  
Insurance      33,777       16,155  
Telephone     10,617       11,977  
 
Of the $4,790,293 in consulting expense for the six months ended June 30, 2008, $3,581,900  relates to the issuance of 11,057  shares of common stock.  In addition, we charged $1,100,000 in consulting fees through an increase in convertible debt by the same amount. Of the $12,177,839 in consulting expense for the six months ended June 30, 2007, $11,967,345 was related to the issuance of 5,715 shares of common stock.  Of the $535,782 in professional fees for the six months ended June 30, 2007, $435,000 relates to the issuance of 300 shares of common stock.

36

 
Other Income and Expenses and Net Loss

Our gain on modification of convertible debt, modification of research and development sponsorship agreement, loss on subscription receivables, interest expense, other-than-temporary impairment of marketable securities, change in fair value of derivative and warrant liabilities, loss on settlement of lawsuits, and net loss for the six months ended June 30, 2008 as compared to the six months ended June 30, 2007 are as follows:

   
Six months
Ended
June 30, 2008
   
Six months
Ended
June 30, 2007
   
Percentage
 Change
 
                   
 Interest expense    $ (977,019 )   $ (1,590,651     (38.58 )%
 Loss on modification of convertible debt      (964,730     --       100.00  %
 Net unrealized and realized loss of marketable securities   $ (8 )   $ (8,556,219 )       (100.00 )%
 Change in fair value of derivative and warrant liabilities    $ (62,544,101 )   $ 22,920,017       (372.88 )%
 Interest income    $ 15,523     $ 15,966       (2.77 )%
 Provision for income taxes     (800     (800     0  %
 Net loss    $ (90,625,653 )     $ (53,132,656 )       (70,56 )%
 
Our interest expense includes amortization of debt discounts totaling $824,073 during the six months ended June 30, 2008 and $1,431,081 during the six months ended June 30, 2007.  The change in fair value of derivative and warrant liabilities represents the change in derivative values related to warrants and convertible debt with Palisades Capital, LLC and Golden Gate Investors.

Liquidity and Capital Resources

Introduction

During the six months ended June 30, 2008, as with the six months ended June 30, 2007, we did not generate positive cash flow.  As a result, we funded our operations through the private sale of equity and debt securities, the issuance of our securities in exchange for services, and loans.

Our cash, investments in marketable securities held for trading, investments in marketable securities available for sale, accounts receivable, prepaid services, prepaid expenses and other current assets, total current assets, total assets, total current liabilities, and total liabilities as of June 30, 2008, as compared to June 30, 2007, were as follows:

37

 
   
June 30, 2008
   
June 30, 2007
 
             
 Cash   $ 530,045     $ 384,628  
 Marketing securities - trading    $ --     $ 342,169  
 Investment in certificate of deposits   $ --     $ 704,800  
 Accounts receivable   $ --     $ 24,920  
 Inventories    $ 148,964     $ --  
 Prepaid expenses and other     $ 62,941     $ 32,323  
 Total current assets   $ 741,950     $ 1,488,840  
 Total assets    $ 836,232     $ 2,139,025  
 Total current liabilities    $ 3,886,056     $ 445,467  
 Total liabilities   $ 11,610,448     $ 3,941,680  
 
Cash Requirements

For the six months ended June 30, 2008, our net cash used in operations was $1,636,659 compared to $1,169,628 for the six months ended June 30, 2007. 

Negative operating cash flows during the six months ended June 30, 2008 were primarily created by a net loss from operations of $90,625,653, offset by the loss on the modification of the Palisades convertible debt of $964,730, issuance of stock for services of $3,625,200, amortization of discount on convertible debentures of $824,073 increase in officer stock based compensation of $19,885,333 and increase in derivative liabilities of $62,544,100.  There was also a decrease in accrued interest on debt of $135,816, net decrease in assets of $104,005 and net decrease in liabilities of $130,968.

Negative operating cash flows during the six months ended June 30, 2007 were primarily created by a net loss from operations of $53,132,656, offset by impairment losses of $19,255,878 incurred in connection with the acquisition of subsidiaries, the issuance of stock for services of $15,558,944 , amortization of discount on convertible debentures of $1,431,081, an increase in accounts payable and accrued expenses of $141,766,an increase in officer stock based compensation of $30,000,000 and a net decrease in assets of $71,238.  There was also a decrease in the fair value of derivative and warrant liabilities of $22,920,017 and accrued interest on debt of $156,901. Because of our need for cash to fund our continuing research and development, we do not have an opinion as to how indicative these results will be of future results.

Sources and Uses of Cash

Net cash provided by (used in) investing activities for the six months ended June 30, 2008 and 2007 were $1,286,636 and $(907,209), respectively.  For the six months ended June 30, 2008 and 2007, the net cash came primarily from the sale of securities and maturities of other investments  in the amount of $1,865,000 and $95,006, respectively, offset by the amount for purchase of securities of $(565,000) and $(700,177), respectively.  Net cash from investment

38


activities during the quarter ended June 30, 2008 was further decreased by the $17,167 on the purchase of property and equipment and increased by an officer loan repayment of $3,803.

Net cash provided by financing activities for the six months ended June 30, 2008 and 2007, was $70,358 and $2,332,169, respectively.  For the six months ended June 30, 2008, the net cash used pertained to the purchase of 200,000 shares of our common stock still held in treasury totaling $3,266 and an increase in the amount of indebtedness of $55,000. In addition, during the six month ended June 30, 2008, the Company received $18,624 through the issuance of 77,600 of its common stock.   For the six months ended June 30, 2007, the net cash came primarily from the sale of common stock and warrants of $2,950,000 and proceeds from convertible debentures and other notes payable of $200,000.

We are not generating sufficient cash flow from operations to fund growth.  We cannot predict when we will begin to generate revenue from the sale of our products, and until that time, we will need to raise additional capital through the sale of our securities.  If we are unsuccessful in raising the required capital, we may have to curtail operations.

Critical Accounting Policies

The discussion and analysis of our financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America.  The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses.  In consultation with our Board of Directors, we have identified the following accounting policies that we believe are key to an understanding of our financial statements.  These are important accounting policies that require management’s most difficult, subjective judgments.

The first critical accounting policy relates to revenue recognition.  Income from our research is recognized at the time services are rendered and billed.

The second critical accounting policy relates to research and development expense.  Costs incurred in the development of our products are expensed as incurred.

The third critical accounting policy relates to the valuation of non-monetary consideration issued for services rendered. We value all services rendered in exchange for our common stock at the quoted price of the shares issued at date of issuance or at the fair value of the services rendered, which ever is more readily determinable.  All other services provided in exchange for other non-monetary consideration is valued at either the fair value of the services received or the fair value of the consideration relinquished, whichever is more readily determinable.

Our accounting policy for equity instruments issued to consultants and vendors in exchange for goods and services follows the provisions of EITF 96-18, Accounting for Equity Instruments That are Issued to Other Than Employees for Acquiring, or in Conjunction with Selling, Goods or Services ” and EITF 00-18, Accounting Recognition for Certain Transactions Involving Equity Instruments Granted to Other Than Employees.”  The measurement date for the fair value of the equity instruments issued is determined at the earlier of (i) the date at which a commitment

39


for performance by the consultant or vendor is reached or (ii) the date at which the consultant or vendor’s performance is complete.  In the case of equity instruments issued to consultants, the fair value of the equity instrument is recognized over the term of the consulting agreement.  In accordance to EITF 00-18, an asset acquired in exchange for the issuance of fully vested, nonforfeitable equity instruments should not be presented or classified as an offset to equity on the grantor’s balance sheet once the equity instrument is granted for accounting purposes.  Accordingly, we record the fair value of nonforfeitable common stock issued for future consulting services as prepaid services in our consolidated balance sheet.

The fourth critical accounting policy is our accounting for conventional convertible debt.  When the convertible feature of the conventional convertible debt provides for a rate of conversion that is below market value, this feature is characterized as a beneficial conversion feature (BCF”).  We record a BCF as a debt discount pursuant to EITF Issue No. 98-5 (EITF 98-05), Accounting for Convertible Securities with Beneficial Conversion Features or Contingency Adjustable Conversion Ratio,” and EITF Issue No. 00-27,  Application of EITF Issue No. 98-5 to Certain Convertible Instrument(s).”   In those circumstances, the convertible debt will be recorded net of the discount related to the BCF.  We amortize the discount to interest expense over the life of the debt using the effective interest method.

The fifth critical account policy relates to the accounting for non-conventional convertible debt and the related stock purchase warrants.  In the case of non-conventional convertible debt, we bifurcate our embedded derivative instruments and record them under the provisions of SFAS No. 133, Accounting for Derivative Instruments and Hedging Activities,” as amended, and EITF Issue No. 00-19, Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Company’s Own Stock.” These embedded derivatives include the conversion feature, liquidated damages related to registration rights and default provisions.  The accounting treatment of derivative financial instruments requires that we record the derivatives and related warrants at their fair values as of the inception date of the agreement and at fair value as of each subsequent balance sheet date.  In addition, under the provisions of EITF Issue No. 00-19, as a result of entering into the non-conventional convertible debenture, we are required to value and classify all other non-employee stock options and warrants as derivative liabilities at that date and mark them to market at each reporting date thereafter.  Any change in fair value will be recorded as non-operating, non-cash income or expense at each reporting date.  If the fair value of the derivatives is higher at the subsequent balance sheet date, we will record a non-operating, non-cash charge.  If the fair value of the derivatives is lower at the subsequent balance sheet date, we will record non-operating, non-cash income.  We value our derivatives primarily using the Black-Scholes Option Pricing Model.  The derivatives are classified as long-term liabilities.

The sixth critical accounting policy relates to the recording of marketable securities held for trading and available-for-sale.  Marketable securities purchased with the intent of selling them in the near term are classified as trading securities.  Trading securities are initially recorded at cost and are adjusted to their fair value, with the change in fair value during the period included in earnings as unrealized gains or losses.  Realized gains or losses on dispositions are based upon the net proceeds and the adjusted book value of the securities sold, using the specific identification method, and are recorded as realized gains or losses in the consolidated statements
 

of operations.  Marketable securities that are not classified as trading securities are classified as available-for-sale securities.  Available-for-sale securities are initially recorded at cost.  Available-for-sale securities with quoted market prices are adjusted to their fair value, subject to an impairment analysis (see below).  Any change in fair value during the period is excluded from earnings and recorded, net of tax, as a component of accumulated other comprehensive income (loss).  Any decline in value of available-for-sale securities below cost that is considered to be other than temporary is recorded as a reduction of the cost basis of the security and is included in the statement of operations as a write down of the market value (see below).

The seventh critical accounting policy is our accounting for the fair market value of non-marketable securities we have acquired.  Non-marketable securities are originally recorded at cost.   In the case of non-marketable securities we acquired with our common stock, we value the securities at a significant discount to the stated per share cost based upon our historical experience with similar transactions as to the amount ultimately realized from the sale of the shares.  Such investments are reduced when we have indications that a permanent decline in value has occurred.  At such time as quoted market prices become available, the net cost basis of these securities will be reclassified to the appropriate category of marketable securities.  Until that time, the securities will be recorded at their net cost basis, subject to an impairment analysis (see below).

In accordance with the guidance of EITF 03-1, The Meaning of Other-Than-Temporary Impairment and Its Application to Certain Investments, we assess any decline in value of available-for-sale securities and non-marketable securities below cost as to whether such decline is other than temporary.  If a decline is determined to be other than temporary, the decline is recorded as a reduction of the cost basis of the security and is included in the statement of operations as an impairment write down of the investment.

Item 3.       Quantitative and Qualitative Disclosures about Market Risk

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.

Item 4.       Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Our President and Chief Financial Officer (the “Certifying Officers”) have evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934) as of the end of period covered by this report.  Based upon such evaluation, the Certifying Officers concluded that our disclosure controls and procedures were not effective to ensure that the information required to be disclosed by us in the reports that we file or submit under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and is accumulated and communicated to our management, including the Certifying Officers, as appropriate to allow timely decisions regarding required disclosure, due to the material weaknesses described below.

 

41


In light of the material weaknesses described below, the Certifying Officers performed additional analysis and other post-closing procedures to ensure our consolidated financial statements were prepared in accordance with generally accepted accounting principles.  Accordingly, we believe that the consolidated financial statements included in this report fairly present, in all material respects, our financial condition, results of operations and cash flows for the periods presented.

A material weakness is a control deficiency (within the meaning of the Public Company Accounting Oversight Board (“PCAOB”) Auditing Standard No. 2) or combination of control deficiencies, that result in more than a remote likelihood that a material misstatement of the annual or interim financial statements will not be prevented or detected.  The Certifying Officers have identified the following three material weaknesses which have caused the Certifying Officers to conclude that our disclosure controls and procedures were not effective at the reasonable assurance level:

1.       We do not yet have written documentation of our internal control policies and procedures.  Written documentation of key internal controls over financial reporting is a requirement of Section 404 of the Sarbanes-Oxley Act and will be applicable to us for the year ending December 31, 2008.  The Certifying Officers evaluated the impact of our failure to have written documentation of our internal controls and procedures on our assessment of our disclosure controls and procedures and have concluded that the control deficiency that resulted represented a material weakness.

2.       We do not have sufficient segregation of duties within accounting functions, which is a basic internal control.  Due to our size and nature, segregation of all conflicting duties may not always be possible and may not be economically feasible.  However, to the extent possible, the initiation of transactions, the custody of assets and the recording of transactions should be performed by separate individuals.  The Certifying Officers evaluated the impact of our failure to have segregation of duties on our assessment of our disclosure controls and procedures and has concluded that the control deficiency that resulted represented a material weakness.

3.       We had a significant number of audit adjustments for the last three fiscal years.  Audit adjustments are the result of a failure of the internal controls to prevent or detect misstatements of accounting information.  The failure could be due to inadequate design of the internal controls or to a misapplication or override of controls.  The Certifying Officers evaluated the impact of our significant number of audit adjustments last year and have concluded that the control deficiency that resulted represented a material weakness. 

On November 27, 2007, our Certifying Officers concluded that in valuing previous periods’ non-cash security transactions, we utilized discounts to the respective share’s trading prices as well as its derivative liabilities which they have determined are without foundation.

As a result of this evaluation and conclusion, the Certifying Officers in conjunction with our Board of Directors concluded that previously issued consolidated financial statements included in our Annual Reports on Form 10-KSB for the fiscal years ended December 31, 2005, 2006, and 2007, as well as all of our quarterly reports on Form 10-QSB during the 2005, 2006 and 2007 fiscal years, could no longer be relied upon.  In this regard, we amended and restated

42


our financial statements to eliminate all discounts and refiled our Annual Report on Form 10-KSB for the fiscal year ended December 31, 2007.  The net effect of the restatements was to increase the accumulated deficit at June 30, 2007 from $100,909,477 to $292,944,478.

The Certifying Officers have discussed this matter with our current independent registered public accounting firm.

To remediate the material weaknesses in our disclosure controls and procedures identified above, in addition to working with our independent auditors, we have continued to refine our internal procedures to begin to implement segregation of duties and to reduce the number of audit adjustments.

Changes in Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting during the period covered by this report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Item 4T.       Controls and Procedures

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.
 
 
 
 
 
 
 
 
 
 

43


PART II – OTHER INFORMATION

Item 1.       Legal Proceedings

Stephen Beck

In July 2002, we settled a lawsuit related to a contract dispute with Mr. Stephen Beck.  In March 2006, Mr. Beck filed a lawsuit against us alleging breach of contract related to the lawsuit settlement and sought monetary damages, plus the issuance of shares of our common stock plus interest.

In December 2006, we entered into a settlement and release agreement, as well as irrevocable escrow instructions, to settle the lawsuit Mr. Beck filed in March 2006.  As consideration under the settlement, we issued 5,000,000 shares of our common stock to Mr. Beck, with the shares to be held by an escrow agent and distributed to Mr. Beck monthly with a trading limit equal to 8% of the previous month’s trading volume of our common stock, until Mr. Beck received a total of $800,000.  As Mr. Beck received proceeds from the sale of his shares into the market and 7.5% (net of any expenses incurred by us) of any cash raised by us from the sale of equity, we would reduce our guarantee by that amount.  We have paid a total of $285,182 to Mr. Beck in cash as part of the settlement.   Mr. Beck also had anti-dilution rights on those shares to maintain his percentage ownership through September 27, 2008.  We issued another 5,000,000 shares to Mr. Beck to be held in escrow until the conditions were met with respect to the anti-dilution shares.  As of the date of this report, we have issued a total of 1,393,617 shares of common stock to Mr. Beck pursuant to the anti-dilution provision in the settlement arrangement.  In or about February 2008, Mr. Beck reached the $800,000 guarantee from the sale of our common stock and the cash received from us for 7.5% of the capital we raised.  Therefore, as of the date of this report, we have no further liability to Mr. Beck.

On September 12, 2007, we filed a complaint for declaratory relief against Mr. Beck in the Superior Court of the State of California, County of Los Angeles, Central Judicial District, seeking a judicial determination as to the respective rights and duties of us and Mr. Beck with respect to certain terms and conditions of the settlement agreement and escrow instructions.

On February 7, 2008, we filed a first amended complaint in our action against Mr. Beck for declaratory relief which now also seeks to have the settlement agreement and escrow instructions rescinded.  On March 6, 2008, Mr. Beck filed a cross-complaint against us and Robert M. Bernstein, our President and a Director, for breach of contract, specific performance, declaratory relief, conversion, intentional interference with contract (against Mr. Bernstein only) and, in the alternative, equitable restitution.  Trial is scheduled for February 2, 2009.

Gem Advisors, Inc., GEM Global Emerging Markets, and Global Emerging Markets of North America, Inc.

On June 15, 2005, we filed a Complaint in the Los Angeles Superior Court, State of California, case number BC336689, against Gem Advisors, Inc., GEM Global Emerging Markets, and Global Emerging Markets of North America, Inc., seeking a declaration regarding certain agreements we entered into with the parties.  We did not seek monetary damages.  On November 16, 2005, Gem Advisors, Inc. filed an Answer and Cross-Complaint, seeking

44

 
approximately $1.9 million in damages arising out of finders fees for certain transactions.  On November 30, 2005, default judgments were entered against the other defendants who failed to respond to our Complaint.  In September 2006, this case was dismissed as to all parties because the parties thought they could agree on the terms of a written settlement agreement.  However, the parties failed to reach a settlement and no formal settlement agreement was ever executed.

On November 30, 2007, Gem Advisors, Inc. filed a lawsuit against us, Robert M. Bernstein, and Lawrence I. Washor (who represented us in the lawsuit against Gem Advisors, Inc. filed on June 15, 2005), for breach of contract (settlement), breach of contract (for transfer to Gem Advisors, Inc. of 585,000 shares we held in another company), breach of covenant of good faith and fair dealing, and fraud and deceit – promise made without intention to perform (the only cause of action asserted against Robert M. Bernstein and Lawrence I. Washor).  Gem Advisors, Inc. is seeking damages in excess of $250,000. On April 10, 2008, the court sustained Lawrence I. Washor’s demurrer to the complaint, and dismissed Lawrence I. Washor from the lawsuit.  Trial is scheduled for October 8, 2008.

Item 1A.       Risk Factors

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.

Item 2.       Unregistered Sales of Equity Securities and Use of Proceeds

On April 11, 2008, we issued a total of 1,040  shares of common stock pursuant to a conversion of Series E Convertible Preferred Stock.  We relied on the exemption from registration relating to offerings that do not involve any public offering pursuant to Section 4(2) under the Securities Act of 1933 (the “Act”) and/or Rule 506 of Regulation D of the Act.  We believe that the investor had adequate access to information about us through the investor’s relationship with us.

On July 11, 2008, we issued a total of 7,538 shares of common stock to two entities pursuant to their conversion of Series E Convertible Preferred Stock.  We relied on the exemption from registration relating to offerings that do not involve any public offering pursuant to Section 4(2) under the Securities Act of 1933 (the “Act”) and/or Rule 506 of Regulation D of the Act.  We believe that each investor had adequate access to information about us through the investor’s relationship with us.

On July 31, 2008, we issued a $1,000,000 10% convertible debenture to Kreuzfeld Ltd. (the “Debenture”).  Interest on the Debenture is payable quarterly and may be paid in either cash or in shares of our common stock, valued at 50% of the average closing price of our common stock on the  ten trading days immediately prior to such share issuance, at our option.  The Debenture is secured by all of our assets pursuant to a Security Agreement, dated July 31, 2008.  All or any portion of the amounts due under the Debenture, which matures on December 31, 2011, may be converted at any time, at the option of Kreuzfeld Ltd., into shares of our common stock at a conversion price equal to the lesser of (i) 50% of the average closing price of our common stock

45


for the ten trading days immediately preceding the conversion date, or (ii) $0.10.  On August 6, 2008, we entered into a Registration Rights Agreement with Kreuzfeld Ltd. pursuant to which we agreed to file with the Securities and Exchange Commission a registration statement to register the Debenture and the shares into which the Debenture is convertible.  Neither the Debenture nor the shares into which the Debenture is convertible have been registered under the Act and may not be offered or sold in the United States absent registration or an applicable exemption from registration.  The issuance of the Debenture was made to one non-U.S. person (as that term is defined in Regulation S of the Act) in an offshore transaction relying on Regulation S and/or Section 4(2) of the Act.

Item 3.       Defaults Upon Senior Securities.

There have been no events which are required to be reported under this item.

Item 4.       Submission of Matters to a Vote of Security Holders.

On April 22, 2008, a majority of our shareholders executed a majority written consent in lieu of an annual meeting to avoid the expenses of holding a formal annual meeting.  The majority shareholders voted to: (a) re-elect the current directors on our Board of Directors (Robert M. Bernstein, William Berks, and Joel R. Freedman); (b) ratify our current capitalization of: 600,000,000 shares of Class A common stock; 600,000 shares of Class B common stock; and 50,000,000 shares of preferred stock; (c) amend our Articles of Incorporation in order to increase our authorized shares of Class A common stock from 600,000,000 to 1,500,000,000; (d) amend our Articles of Incorporation to effect a one for 1,000 reverse stock split; (e) amend our Articles of Incorporation to change our name to Matech Corp.; (f) authorize our 2008 Stock Option Plan; and (g) ratify our appointment of Gruber & Co., LLC as our independent public accountants.

Item 5.       Other Information.

None.

Item 6.       Exhibits.

10.1 *
License Agreement with Fatigue Solutions Corp., dated May 21, 2008
   
10.2 *
Business Agreement with The India-America Technology Agency, dated May 25, 2008
   
10.3 *
Indemnification Agreement with Marybeth Miceli Newton, dated June 5, 2008
   
10.4 *
Teaming Agreement with e-RADLIK, Inc., dated June 6, 2008
   
10.5 *
Convertible Debenture issued to Kreuzfeld, Ltd., dated July 31, 2008
   
10.6 *
Security Agreement with Kreuzfeld, Ltd., dated July 31, 2008
   
10.7 *
Financing Escrow Agreement with Continental Advisors, SA and Corporate Legal Services, LLP, dated July 31, 2008
 
 
 
10.8 *
Registration Rights Agreement with Kreuzfeld, Ltd., dated August 6, 2008
   
   
   
 
* Previously filed.
SIGNATURES

In accordance with the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, duly authorized.
 
Dated: August 3, 2009
/s/ Robert M. Bernstein  
   By: 
Robert M. Bernstein
 
   Its: President, Chief Executive Officer,  
    and Chief Financial Officer (Principal  
    Executive Officer, Principal Financial  
    Officer and Principal Accounting Officer)  
 
 
 
 
 
 
 
 
 
 

 
 
47